Taking stock: How China’s end-of-year policies will shape 2025

Taking stock: How China’s end-of-year policies will shape 2025

Beijing's final politburo meeting for 2025 and Central Economic Work Conference (CEWC) offer a timely temperature check on the economy – an opportunity to take stock of current issues and chart a trajectory for growth in 2025.
What businesses in APAC should expect under a second Trump administration: Opportunities, challenges, and takeaways

What businesses in APAC should expect under a second Trump administration: Opportunities, challenges, and takeaways

As Americans head to the polls in an election that may well come down to the wire, now is our chance to take final stock of what the post-election future may hold for those impacted by China-U.S. relations, including the many businesses for which both markets are essential.
Sandpiper Appoints Liz Egginton to Lead Technology Practice

Sandpiper Appoints Liz Egginton to Lead Technology Practice

Based in Australia, Liz will lead the development and long-term growth of the firm’s Technology practice across Asia Pacific, integrating Sandpiper’s world-class offerings, including Content Strategy, Research and Insights, Government Affairs, Reputation Management, and International Media, to drive intentional and strategic communications outcomes for clients.
24 hours to go: What comes next for U.S.-China relations after the election?

24 hours to go: What comes next for U.S.-China relations after the election?

As Americans head to the polls in an election that may well come down to the wire, now is our chance to take final stock of what the post-election future may hold for those impacted by China-U.S. relations, including the many businesses for which both markets are essential.
Top Trends to Shape Healthcare in 2024

Top Trends to Shape Healthcare in 2024

2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.